Jeffrey S. Farrow sold Tarsus Pharmaceuticals ($TARS) shares on the open market four times over the last year, totaling about $728 thousand. His most recent sale occurred on June 17, 2025. These transactions rank 5,646th among 11,678 individual insiders by sale value, compared to an average of $8.6 million per insider and about 6.4 sales. Farrow made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | S | Common Stock | 2111 | $69.42 | 47,635.0000 | 42,607,717 | 4.24% | 0.00% |
| March 19, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | S | Common Stock | 2186 | $67.00 | 43,316.0000 | 42,607,717 | 4.80% | 0.01% |
| March 18, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | S | Common Stock | 2133 | $68.71 | 45,502.0000 | 42,607,717 | 4.48% | 0.01% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | M | Restricted Stock Units | 8020 | $0.00 | 16,040.0000 | 42,607,717 | 33.33% | 0.02% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | M | Restricted Stock Units | 5022 | $0.00 | 15,067.0000 | 42,607,717 | 25.00% | 0.01% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | M | Common Stock | 13042 | $0.00 | 49,746.0000 | 42,607,717 | 35.53% | 0.03% |
| March 5, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | A | Restricted Stock Units | 19306 | $0.00 | 19,306.0000 | 42,607,717 | 9999.99% | 0.05% |
| March 5, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | A | Stock Option (right to buy) | 30724 | $0.00 | 30,724.0000 | 42,607,717 | 9999.99% | 0.07% |
| June 16, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | M | Restricted Stock Units | 27881 | $0.00 | 55,763.0000 | 37,604,538 | 33.33% | 0.07% |
| June 16, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | M | Common Stock | 27881 | $0.00 | 50,312.0000 | 37,604,538 | 124.30% | 0.07% |
| June 17, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | S | Common Stock | 13608 | $40.42 | 36,704.0000 | 37,604,538 | 27.05% | 0.04% |
| March 20, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | S | Common Stock | 1186 | $50.11 | 22,431.0000 | 37,604,538 | 5.02% | 0.00% |
| March 18, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | S | Common Stock | 1284 | $46.29 | 24,871.0000 | 37,604,538 | 4.91% | 0.00% |
| March 19, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | S | Common Stock | 1254 | $47.40 | 23,617.0000 | 37,604,538 | 5.04% | 0.00% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | M | Common Stock | 8019 | $0.00 | 26,155.0000 | 37,604,538 | 44.22% | 0.02% |
| March 17, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | M | Restricted Stock Units | 8019 | $0.00 | 24,060.0000 | 37,604,538 | 25.00% | 0.02% |
| March 5, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | A | Stock Option (right to buy) | 30628 | $0.00 | 30,628.0000 | 37,604,538 | 9999.99% | 0.08% |
| March 5, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | A | Restricted Stock Units | 20089 | $0.00 | 20,089.0000 | 37,604,538 | 9999.99% | 0.05% |
| June 17, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | M | Common Stock | 27881 | $0.00 | 28,581.0000 | 29,383,276 | 3983.00% | 0.09% |
| June 17, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | M | Restricted Stock Units | 27881 | $0.00 | 83,644.0000 | 29,383,276 | 25.00% | 0.09% |
| June 18, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | S | Common Stock | 10445 | $27.47 | 18,136.0000 | 29,383,276 | 36.55% | 0.04% |
| March 7, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | A | Stock Option (right to buy) | 47500 | $0.00 | 47,500.0000 | 29,383,276 | 9999.99% | 0.16% |
| March 7, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | A | Restricted Stock Units | 32079 | $0.00 | 32,079.0000 | 29,383,276 | 9999.99% | 0.11% |
| April 24, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | A | Stock Option (right to buy) | 163397 | $0.00 | 163,397.0000 | 24,619,700 | 9999.99% | 0.66% |
| April 24, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Farrow Jeffrey S | See Remarks | A | Restricted Stock Units | 111525 | $0.00 | 111,525.0000 | 24,619,700 | 9999.99% | 0.45% |